Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.

Pathology in most chronic inflammatory diseases is characterized by an imbalance in cytokine expression. Targeting cytokines with monoclonal antibodies has proven to be a highly effective treatment. However, monoclonal antibody therapy has disadvantages such as high production costs, generation of a...

Полное описание

Библиографические подробности
Главные авторы: Link, A, Bachmann, M
Формат: Journal article
Язык:English
Опубликовано: 2010